About

About SciBase SciBase is a global medical technology company specializing in dermatology, with a focus on early detection, prevention, and advanced skin barrier science. The company develops, manufactures, and commercializes Nevisense, a unique point-of-care platform that combines AI and advanced Electrical Impedance Spectroscopy (EIS) technology to elevate diagnostic accuracy and enable proactive skin health management. Beyond skin cancer diagnostics, SciBase is a leader in skin barrier science and cosmetic testing, providing advanced solutions to objectively assess skin properties and support product development and clinical research within the pharmaceutical and the cosmetic industry. The company has been listed on the Nasdaq First North Growth Market since June 2, 2015. Learn more at www.scibase.com SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a unique point-of-care platform that combines AI and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs. Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements. The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015.